These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31980638)

  • 1. Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease.
    Parker JD; D' Iorio M; Floras JS; Toal CB
    Sci Rep; 2020 Jan; 10(1):565. PubMed ID: 31980638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics.
    Wenzel RR; Allegranza G; Binggeli C; Shaw S; Weidmann P; Lüscher TF; Noll G
    J Am Coll Cardiol; 1997 Jun; 29(7):1607-14. PubMed ID: 9180126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
    Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
    J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.
    Toal CB; Meredith PA; Elliott HL
    Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients.
    Brown MJ; Toal CB
    Br J Clin Pharmacol; 2008 May; 65(5):646-52. PubMed ID: 18093252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
    Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
    Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertension.
    Ruzicka M; Coletta E; Floras J; Leenen FH
    J Hypertens; 2004 May; 22(5):1039-44. PubMed ID: 15097246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.
    Lindqvist M; Kahan T; Melcher A; Hjemdahl P
    Hypertension; 1994 Sep; 24(3):287-96. PubMed ID: 8082934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium antagonists on sympathetic activity.
    Grossman E; Messerli FH
    Eur Heart J; 1998 Jun; 19 Suppl F():F27-31. PubMed ID: 9651732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
    Ragueneau I; Sao AB; Démolis JL; Darné B; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2001 Mar; 69(3):122-9. PubMed ID: 11240976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension.
    Fogari R; Mugellini A; Zoppi A; Corradi L; Rinaldi A; Derosa G; Preti P
    Am J Hypertens; 2003 Jul; 16(7):596-9. PubMed ID: 12850395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
    Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
    J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension.
    Pellizzer AM; Kamen PW; Esler MD; Lim S; Krum H
    J Hypertens; 2001 Feb; 19(2):279-85. PubMed ID: 11212971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
    Burger W; Neidel S; Kober G
    Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine.
    Kiowski W; Erne P; Bertel O; Bolli P; Bühler F
    J Am Coll Cardiol; 1986 Feb; 7(2):344-8. PubMed ID: 3944353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
    Lüscher TF; Pieper M; Tendera M; Vrolix M; Rutsch W; van den Branden F; Gil R; Bischoff KO; Haude M; Fischer D; Meinertz T; Münzel T
    Eur Heart J; 2009 Jul; 30(13):1590-7. PubMed ID: 19474053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N; Naranca M; Vujic-Podlipec D; Bagatin J; Rumboldt Z
    Arzneimittelforschung; 2002; 52(5):379-84. PubMed ID: 12087923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease.
    Kloke HJ; Wetzels JF; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
    Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.